Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer. - Test2 - elhamkhani - TriplyDB

Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.

Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.

http://www.wikidata.org/entity/Q34838226

about

Skp2: a novel potential therapeutic target for prostate cancer E3-ligase Skp2 predicts poor prognosis and maintains cancer stem cell pool in nasopharyngeal carcinoma.The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth.Bone-induced c-kit expression in prostate cancer: a driver of intraosseous tumor growth.Mitochondrial DNA depletion sensitizes cancer cells to PARP inhibitors by translational and post-translational repression of BRCA2.Ubiquitin-specific protease 21 stabilizes BRCA2 to control DNA repair and tumor growth.Skp2 and its emerging role in the pathogenesis of systemic malignancies besides breast carcinomas.S-phase kinase-associated protein 2 is involved in epithelial-mesenchymal transition in methotrexate-resistant osteosarcoma cells.

P2860

Q24625558-70B9595C-BB6B-4428-91AF-BB52CFEEFD6D Q34221801-FF3158C5-9602-4A51-8BA5-3436433AB30F Q34227747-189486D5-15B7-41BE-8240-4AE6C2E3E5E7 Q34353130-0CC66B8C-34A2-4094-90FC-22BB9DA0C06A Q37614527-429E0B51-425F-4099-8810-DB3031AD2DC8 Q41124714-59F229D6-AFDF-4FBE-B57B-5C770F079BE3 Q42424762-4989ABA6-92E1-448F-9101-33D63AA01EBE Q52605294-BCEA5DF3-6938-4FA0-B6CD-4F3EBBA84ED7

P2860

Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.

http://www.wikidata.org/entity/Q34838226

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.

@ast

Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.

@en

Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.

@nl

type

label

Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.

@ast

Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.

@en

Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.

@nl

prefLabel

Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.

@ast

Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.

@en

Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.

@nl

P1433

Q34838226-9842EF6D-EB24-4D7D-9757-F02131F69289

P1476

Q34838226-A543FCC1-C643-42BC-85EC-4EAE2CE54CE8

P2093

Q34838226-0F96CE75-4FD2-41D0-AE74-A9AFBF83CDFB

Q34838226-1716F01A-7FFC-4CDA-B04E-EC42551AE7F6

Q34838226-55F524FF-8879-464D-84A7-849B235ED25E

Q34838226-6D90016C-BD35-423A-B39D-CDB350EC51E1

Q34838226-74C12859-D0BD-453D-AB39-2DF0438C8803

Q34838226-C2E8C5A7-80DB-4D1C-885A-6431C2CB95CA

Q34838226-C6EB16A1-81D5-485A-9BA3-E0CC138FB233

P2860

Q34838226-0A943AE8-64A0-44D4-813C-13547474944A

Q34838226-1C33B3F0-DF71-4DD2-955F-4B89B6C80EE6

Q34838226-2003C735-932A-42B9-9CBD-48A763E065FF

Q34838226-21803E8D-18E1-4B8B-9F2F-14B0F770F110

Q34838226-2AAD6199-9A09-4487-818B-1883393EE110

Q34838226-2D1AC0AA-9582-42B5-8DE4-B0FD39BA244D

Q34838226-34292D8C-E7E3-4455-855C-117C9EE70470

Q34838226-370F6C9E-236B-4DC5-8FCC-3879C44BD628

Q34838226-382E6551-F34B-4AF2-B51D-4209247B313C

Q34838226-3EE388F3-2FCF-4547-A72D-C80AB63265C0

P304

Q34838226-CEF382F6-4774-4F7B-AF0A-E3C34DC9D8F1

P31

Q34838226-BD09B2E5-AFEF-4B2D-836A-0C8C63AEDB5C

P356

Q34838226-511DBE1C-EE3C-429A-BDC9-042FF3423BBF

P407

Q34838226-DBBA1EAB-127A-4281-87CE-FF49CCF2912D

P433

Q34838226-C75A2FCB-C55D-4347-B569-E2B8B125E5C2

P478

Q34838226-36880A3F-EE58-4A15-9CDC-BAEECCA5EEA3

P50

Q34838226-CE126205-865D-4B03-ACF9-B232FAB3A2F5

P577

Q34838226-40BC46EB-2462-4C83-B997-23319FEEEBF7

P5875

Q34838226-67DBB26E-70D5-4181-AB93-57CE742767CD

P698

Q34838226-1DCEB729-2615-4168-B7AA-3B780F8602BF

P921

Q34838226-D5EA354A-19FA-4C25-992D-0901C76D3353

P932

Q34838226-C13DCEDD-4180-4269-9A70-142918B3F1ED

P356

J.AJPATH.2011.01.050

P1433

The American Journal of Pathology

P1476

Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.

@en

P2093

Arnaldo A Arbini

http://www.w3.org/2001/XMLSchema#string

Jer-Tsong Hsieh

http://www.w3.org/2001/XMLSchema#string

Jorge L Yao

http://www.w3.org/2001/XMLSchema#string

Loredana Moro

http://www.w3.org/2001/XMLSchema#string

Margherita Greco

http://www.w3.org/2001/XMLSchema#string

Patricia Bourne

http://www.w3.org/2001/XMLSchema#string

Paul A di Sant'agnese

http://www.w3.org/2001/XMLSchema#string

P2860

BRCA2 is ubiquitinated in vivo and interacts with USP11, a deubiquitinating enzyme that exhibits prosurvival function in the cellular response to DNA damage

BRCA2 suppresses cell proliferation via stabilizing MAGE-D1

Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer

Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia

Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction

Role of the F-box protein Skp2 in lymphomagenesis

Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence

Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB

BRCA2 acts as a RAD51 loader to facilitate telomere replication and capping

EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer

P304

2367-2376

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AJPATH.2011.01.050

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

178

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51071516

http://www.w3.org/2001/XMLSchema#string

P698

21514447

http://www.w3.org/2001/XMLSchema#string

P921

P932

3081144

http://www.w3.org/2001/XMLSchema#string